Investment Analysts’ Weekly Ratings Updates for Bath & Body Works (BBWI)

Bath & Body Works (NYSE: BBWI) has recently received a number of price target changes and ratings updates:

• 1/14/2026 – Bath & Body Works is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $24.00 price target on the stock.
• 1/8/2026 – Bath & Body Works had its price target raised by analysts at UBS Group AG from $17.00 to $21.00. They now have a “neutral” rating on the stock.
• 1/8/2026 – Bath & Body Works is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $21.00 price target on the stock.
• 1/6/2026 – Bath & Body Works had its price target raised by analysts at Barclays PLC from $18.00 to $20.00. They now have an “equal weight” rating on the stock.
• 12/17/2025 – Bath & Body Works was given a new $20.00 price target on by analysts at Robert W. Baird.
• 12/9/2025 – Bath & Body Works is now covered by analysts at Guggenheim. They set a “neutral” rating on the stock.
• 11/24/2025 – Bath & Body Works was given a new $26.00 price target on by analysts at New Street Research.
• 11/24/2025 – Bath & Body Works was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at UBS Group AG from $32.00 to $17.00. They now have a “neutral” rating on the stock.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Citigroup Inc. from $35.00 to $21.00. They now have a “buy” rating on the stock.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Wells Fargo & Company from $33.00 to $25.00. They now have an “overweight” rating on the stock.
• 11/21/2025 – Bath & Body Works was downgraded by analysts at Telsey Advisory Group from an “outperform” rating to a “market perform” rating. They now have a $17.00 price target on the stock, down previously from $38.00.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Barclays PLC from $28.00 to $18.00. They now have an “equal weight” rating on the stock.
• 11/21/2025 – Bath & Body Works had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $18.00 price target on the stock, down previously from $43.00.
• 11/21/2025 – Bath & Body Works was downgraded by analysts at Baird R W from a “strong-buy” rating to a “hold” rating.
• 11/20/2025 – Bath & Body Works was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $17.00 price target on the stock, down previously from $39.00.
• 11/20/2025 – Bath & Body Works had its “neutral” rating reaffirmed by analysts at Robert W. Baird. They now have a $19.00 price target on the stock, down previously from $33.00.
• 11/20/2025 – Bath & Body Works had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $15.00. They now have a “neutral” rating on the stock.
• 11/20/2025 – Bath & Body Works had its price target lowered by analysts at Bank of America Corporation from $40.00 to $32.00. They now have a “buy” rating on the stock.
• 11/20/2025 – Bath & Body Works had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $17.00 price target on the stock, down previously from $38.00.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Friday, November 21st were paid a $0.20 dividend. The ex-dividend date was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a yield of 3.4%. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.

Insiders Place Their Bets

In related news, Director Stephen D. Steinour acquired 6,700 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $14.86 per share, with a total value of $99,562.00. Following the transaction, the director directly owned 48,175 shares of the company’s stock, valued at $715,880.50. This trade represents a 16.15% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Francis Hondal bought 3,343 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average price of $14.99 per share, with a total value of $50,111.57. Following the completion of the purchase, the director directly owned 21,554 shares in the company, valued at $323,094.46. This represents a 18.36% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 33,513 shares of company stock worth $500,442 in the last three months. Insiders own 0.26% of the company’s stock.

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.